November 2023

New study advances the understanding of the resistance mechanisms of ‘Haemophilus parainfluenzae’

This finding, published in the International Journal of Antimicrobial Agents, highlights the possibility that this resistance mechanism could spread to other sexually transmitted pathogens.

New study advances the understanding of the resistance mechanisms of ‘Haemophilus parainfluenzae’ Read More »

IDIBELL joins the “COMBINE” project as an EATRIS Expert Centre to streamline interface between clinical trials, in vitro diagnostics, and medical device investigations

EATRIS, the European Infrastructure for Translational Medicine, has just announced its participation in the stakeholders’ advisory group in the ‘COMBINE’ project, an initiative aimed at providing clarity and alignment at the interface between clinical trials of investigational medicinal products, performance studies of in vitro diagnostics, and clinical investigations of medical devices.   COMBINE is an

IDIBELL joins the “COMBINE” project as an EATRIS Expert Centre to streamline interface between clinical trials, in vitro diagnostics, and medical device investigations Read More »

Scroll to Top